Denali Therapeutics (DNLI) Other Gross PP&E Adjustments (2017 - 2025)
Denali Therapeutics (DNLI) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with -$745000.0 as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 137.65% to -$745000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$745000.0 through Dec 2025, down 137.65% year-over-year, with the annual reading at -$745000.0 for FY2025, 137.65% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$745000.0 at Denali Therapeutics, up from -$20.0 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $12.3 million in Q4 2023, with the low at -$47.4 million in Q2 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$20.2 million, with a median of -$26.0 million recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments surged 92.71% in 2023, then tumbled 137.65% in 2025.
- Over 5 years, Other Gross PP&E Adjustments stood at $7.3 million in 2021, then dropped by 12.21% to $6.4 million in 2022, then soared by 92.71% to $12.3 million in 2023, then tumbled by 83.93% to $2.0 million in 2024, then crashed by 137.65% to -$745000.0 in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$745000.0, -$20.0 million, and -$47.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.